Baird Medical Highlights Johns Hopkins University Research Demonstrating Clinical and Economic Benefits of Thyroid Nodule Ablation [Yahoo! Finance]
Baird Medical Investment Holdings Ltd - Ordinary Share (BDMD)
Company Research
Source: Yahoo! Finance
the "Company"), a global leader in minimally invasive Microwave Ablation (MWA) technology, highlighted the significant findings of a cost-utility analysis conducted by researchers at Johns Hopkins University. The study abstract, presented at the recent American Thyroid Association (ATA) Annual Meeting, concludes that management strategies incorporating transcutaneous thyroid nodule ablation (TNA) can lead to lower healthcare costs and improved patient quality of life. Baird Medical (PRNewsfoto/Baird Medical LLC) The independent research, "Cost-Utility Analysis of Management Strategies Incorporating Transcutaneous Thyroid Nodule Ablation for Benign and Malignant Thyroid Nodules," developed a health economic model to compare TNA with traditional approaches such as surgery and observation. The model revealed that incorporating TNA into treatment plans resulted in projected per-patient cost savings of $1,641 for benign nodules and $380 for thyroid microcarcinomas over a five-year hori
Show less
Read more
Impact Snapshot
Event Time:
BDMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BDMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BDMD alerts
High impacting Baird Medical Investment Holdings Ltd - Ordinary Share news events
Weekly update
A roundup of the hottest topics
BDMD
News
- Baird Medical Appoints Mark Saxton as U.S. CEO; Taps Veteran from NeuroPace, Smith + Nephew, and Covidien to Lead Commercial ExpansionPR Newswire
- Baird Medical Enters Egyptian Market with First Successful Bone Tumor AblationPR Newswire
- Baird Medical Investment (NASDAQ:BDMD) had its "sell (d)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Baird Medical's MWA System Achieves Successful Medicare Reimbursement at Prominent New York PracticePR Newswire
- Baird Medical Announces First Successful Liver Tumor Ablation in BangladeshPR Newswire
BDMD
Sec Filings
- 12/5/25 - Form F-1/A
- 12/5/25 - Form 6-K
- BDMD's page on the SEC website